Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine

scientific article published in June 2005

Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2036.2005.02477.X
P698PubMed publication ID15943850
P5875ResearchGate publication ID7798244

P2093author name stringSuzuki K
Kusunoki M
Nakajima A
Wada K
Miyake K
Tsukui T
Hiratsuka T
Nishigaki H
Yoshino S
Ueki N
Sakamoto C
Futagami S
Shinji Y
Tatsuguchi A
P2860cites workGastric mucosal defences in the elderlyQ30728023
Gastrointestinal effects of nonsteroidal anti-inflammatory therapyQ33676713
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.Q34459461
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisQ34520598
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of GastroenterologyQ39467321
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazoleQ43861367
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trialQ44219950
Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsQ57945428
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
famotidineQ411159
P304page(s)67-72
P577publication date2005-06-01
P1433published inAlimentary Pharmacology & TherapeuticsQ4726656
P1476titlePreventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine
P478volume21 Suppl 2

Reverse relations

cites work (P2860)
Q43297764A fixed dose combination of ibuprofen and famotidine
Q79745265Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy)
Q36412892Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study
Q38123737Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy
Q37385351Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors

Search more.